Reviewing RBC Life Sciences (OTCMKTS:RBCL) and Owens & Minor (NYSE:OMI)

RBC Life Sciences (OTCMKTS:RBCL) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Earnings & Valuation

This table compares RBC Life Sciences and Owens & Minor”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RBC Life Sciences	N/A	N/A	N/A	N/A	N/A
Owens & Minor	$10.77 billion	0.02	-$362.69 million	($17.40)	-0.17

RBC Life Sciences has higher earnings, but lower revenue than Owens & Minor.

Institutional and Insider Ownership

98.0% of Owens & Minor shares are held by institutional investors. 45.8% of RBC Life Sciences shares are held by insiders. Comparatively, 3.7% of Owens & Minor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for RBC Life Sciences and Owens & Minor, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RBC Life Sciences	0	0	0	0	0.00
Owens & Minor	4	0	3	0	1.86

Owens & Minor has a consensus price target of $6.35, indicating a potential upside of 119.34%. Given Owens & Minor’s stronger consensus rating and higher possible upside, analysts plainly believe Owens & Minor is more favorable than RBC Life Sciences.

Volatility & Risk

RBC Life Sciences has a beta of -21.38, suggesting that its stock price is 2,238% less volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Profitability

This table compares RBC Life Sciences and Owens & Minor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RBC Life Sciences	N/A	N/A	N/A
Owens & Minor	-19.99%	95.57%	2.30%

Summary

Owens & Minor beats RBC Life Sciences on 8 of the 10 factors compared between the two stocks.

About RBC Life Sciences

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

About Owens & Minor

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.